IBDEI0XQ ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16418,0)
 ;;=793.19^^84^975^3
 ;;^UTILITY(U,$J,358.3,16418,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16418,1,3,0)
 ;;=3^793.19
 ;;^UTILITY(U,$J,358.3,16418,1,4,0)
 ;;=4^Abnormal Chest Xray
 ;;^UTILITY(U,$J,358.3,16418,2)
 ;;=^340571
 ;;^UTILITY(U,$J,358.3,16419,0)
 ;;=786.05^^84^975^27
 ;;^UTILITY(U,$J,358.3,16419,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16419,1,3,0)
 ;;=3^786.05
 ;;^UTILITY(U,$J,358.3,16419,1,4,0)
 ;;=4^Shortness of Breath
 ;;^UTILITY(U,$J,358.3,16419,2)
 ;;=^37632
 ;;^UTILITY(U,$J,358.3,16420,0)
 ;;=250.00^^84^976^2
 ;;^UTILITY(U,$J,358.3,16420,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16420,1,3,0)
 ;;=3^250.00
 ;;^UTILITY(U,$J,358.3,16420,1,4,0)
 ;;=4^DM,Type II
 ;;^UTILITY(U,$J,358.3,16420,2)
 ;;=^33605
 ;;^UTILITY(U,$J,358.3,16421,0)
 ;;=276.9^^84^976^3
 ;;^UTILITY(U,$J,358.3,16421,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16421,1,3,0)
 ;;=3^276.9
 ;;^UTILITY(U,$J,358.3,16421,1,4,0)
 ;;=4^Fluid/Electrolyte Abnormality
 ;;^UTILITY(U,$J,358.3,16421,2)
 ;;=^267949
 ;;^UTILITY(U,$J,358.3,16422,0)
 ;;=250.01^^84^976^1
 ;;^UTILITY(U,$J,358.3,16422,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16422,1,3,0)
 ;;=3^250.01
 ;;^UTILITY(U,$J,358.3,16422,1,4,0)
 ;;=4^DM,Type I
 ;;^UTILITY(U,$J,358.3,16422,2)
 ;;=^331780
 ;;^UTILITY(U,$J,358.3,16423,0)
 ;;=285.9^^84^977^1
 ;;^UTILITY(U,$J,358.3,16423,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16423,1,3,0)
 ;;=3^285.9
 ;;^UTILITY(U,$J,358.3,16423,1,4,0)
 ;;=4^Anemia
 ;;^UTILITY(U,$J,358.3,16424,0)
 ;;=785.6^^84^977^3
 ;;^UTILITY(U,$J,358.3,16424,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16424,1,3,0)
 ;;=3^785.6
 ;;^UTILITY(U,$J,358.3,16424,1,4,0)
 ;;=4^Lymphadenopathy
 ;;^UTILITY(U,$J,358.3,16425,0)
 ;;=V58.61^^84^977^2
 ;;^UTILITY(U,$J,358.3,16425,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16425,1,3,0)
 ;;=3^V58.61
 ;;^UTILITY(U,$J,358.3,16425,1,4,0)
 ;;=4^Anti-coagulation use
 ;;^UTILITY(U,$J,358.3,16425,2)
 ;;=Anti-coagulation use^303459
 ;;^UTILITY(U,$J,358.3,16426,0)
 ;;=380.10^^84^978^1
 ;;^UTILITY(U,$J,358.3,16426,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16426,1,3,0)
 ;;=3^380.10
 ;;^UTILITY(U,$J,358.3,16426,1,4,0)
 ;;=4^Otitis Externa
 ;;^UTILITY(U,$J,358.3,16427,0)
 ;;=382.9^^84^978^2
 ;;^UTILITY(U,$J,358.3,16427,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16427,1,3,0)
 ;;=3^382.9
 ;;^UTILITY(U,$J,358.3,16427,1,4,0)
 ;;=4^Otitis Media
 ;;^UTILITY(U,$J,358.3,16428,0)
 ;;=465.9^^84^978^3
 ;;^UTILITY(U,$J,358.3,16428,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16428,1,3,0)
 ;;=3^465.9
 ;;^UTILITY(U,$J,358.3,16428,1,4,0)
 ;;=4^URI
 ;;^UTILITY(U,$J,358.3,16428,2)
 ;;=URI^269878
 ;;^UTILITY(U,$J,358.3,16429,0)
 ;;=401.9^^84^979^1
 ;;^UTILITY(U,$J,358.3,16429,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16429,1,3,0)
 ;;=3^401.9
 ;;^UTILITY(U,$J,358.3,16429,1,4,0)
 ;;=4^Hypertension
 ;;^UTILITY(U,$J,358.3,16430,0)
 ;;=458.0^^84^979^2
 ;;^UTILITY(U,$J,358.3,16430,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16430,1,3,0)
 ;;=3^458.0
 ;;^UTILITY(U,$J,358.3,16430,1,4,0)
 ;;=4^Orthostatic Hypotension
 ;;^UTILITY(U,$J,358.3,16431,0)
 ;;=443.9^^84^979^3
 ;;^UTILITY(U,$J,358.3,16431,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16431,1,3,0)
 ;;=3^443.9
 ;;^UTILITY(U,$J,358.3,16431,1,4,0)
 ;;=4^Periph Vascular Dis 
 ;;^UTILITY(U,$J,358.3,16432,0)
 ;;=451.11^^84^979^4
 ;;^UTILITY(U,$J,358.3,16432,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16432,1,3,0)
 ;;=3^451.11
 ;;^UTILITY(U,$J,358.3,16432,1,4,0)
 ;;=4^Phlebitis  
 ;;^UTILITY(U,$J,358.3,16433,0)
 ;;=724.5^^84^980^1
 ;;^UTILITY(U,$J,358.3,16433,1,0)
 ;;=^358.31IA^4^2
 ;;
 ;;$END ROU IBDEI0XQ
